Isolated cases of acute coronary syndrome (ACS) associated with immune checkpoint inhibitors (ICIs) have been described without

 

Abstract

Isolated cases of acute coronary syndrome (ACS) associated with immune checkpoint inhibitors (ICIs) have been described without the establishment of a formal cause-and-effect relationship between treatment and adverse event. We reported a case of ACS after the first administration of an ICI and with a fatal recurrence in another coronary area immediately after readministration. According to guidelines, causality was considered to be certain. Subsequently, we queried the French pharmacovigilance database and found 4 cases of ACS with coronary artery thrombosis. Causality was probable in those patients. These data suggest that ACS may be another life-threatening cardiac adverse event occurring with ICI exposure.

PMID: 32144037 [PubMed - as supplied by publisher]

13:36

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

13:36

In reply to this message

pubmed: ctoall&ca or conall

Acute and Chronic Effects of Cancer Drugs on the Cardiovascular System.

Related Articles

Acute and Chronic Effects of Cancer Drugs on the Cardiovascular System.

Heart Fail Clin. 2020 Apr;16(2):231-241

Authors: Moriyama S, Fukata M, Kusaba H, Maruyama T, Akashi K